Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action
Open Access
- 2 April 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4), e60302
- https://doi.org/10.1371/journal.pone.0060302
Abstract
Recently, the covalent binding of a cholesterol moiety to a classical HIV-1 fusion inhibitor peptide, C34, was shown to potentiate its antiviral activity. Our purpose was to evaluate the interaction of cholesterol-conjugated and native C34 with membrane model systems and human blood cells to understand the effects of this derivatization. Lipid vesicles and monolayers with defined compositions were used as model membranes. C34-cholesterol partitions more to fluid phase membranes that mimic biological membranes. Importantly, there is a preference of the conjugate for liquid ordered membranes, rich in cholesterol and/or sphingomyelin, as observed both from partition and surface pressure studies. In human erythrocytes and peripheral blood mononuclear cells (PBMC), C34-cholesterol significantly decreases the membrane dipole potential. In PBMC, the conjugate was 14- and 115-fold more membranotropic than T-1249 and enfuvirtide, respectively. C34 or cholesterol alone did not show significant membrane activity. The enhanced interaction of C34-cholesterol with biological membranes correlates with its higher antiviral potency. Higher partitions for lipid-raft like compositions direct the drug to the receptor-rich domains where membrane fusion is likely to occur. This intermediary membrane binding step may facilitate the drug delivery to gp41 in its pre-fusion state.This publication has 51 references indexed in Scilit:
- Preclinical Evaluation of the HIV-1 Fusion Inhibitor L'644 as a Potential Candidate MicrobicideAntimicrobial Agents and Chemotherapy, 2012
- Differential Effect of Cholesterol and Its Biosynthetic Precursors on Membrane Dipole PotentialBiophysical Journal, 2012
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- An Albumin-Conjugated Peptide Exhibits Potent Anti-HIV Activity and LongIn VivoHalf-LifeAntimicrobial Agents and Chemotherapy, 2010
- Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 VirionsPLOS ONE, 2009
- Peptides in the treatment of AIDSCurrent Opinion in Structural Biology, 2009
- Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potencyProceedings of the National Academy of Sciences of the United States of America, 2009
- Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor: EQUIPOTENT TO C34 AND T-20 IN VITRO WITH SUSTAINED ACTIVITY IN SCID-HU THY/LIV MICEOnline Journal of Public Health Informatics, 2008
- Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS SusceptibilityCell Host & Microbe, 2008
- Partial molecular volumes of lipids and cholesterolChemistry and Physics of Lipids, 2006